ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,660, issued on Aug. 11, was assigned to EISAI R&D MANAGEMENT Co. LTD. (Tokyo).
"Method for treating cancer with an oral dosage form of an estrogen receptor-alpha inhibitor" was invented by Jianjun Xiao (Lexington, Mass.), Nathalie M. Rioux (Woburn, Mass.) and Victoria Rimkunas (Reading, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions comprising an inhibitor of human ERAlpha, and methods of cancer therapy using the ERAlpha inhibitor. In particular, described herein are dosages of H3B-6545 with defined pharmacokinetic (PK) profiles that allow the inhibitor to be efficaciously and safely...